Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Ansell

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Haematologica|July 10, 2012
Molecular pathogenesis of Waldenstrom's macroglobulinemiaEsteban Braggio, Casey Philipsborn, Anne Novak, et al.
Cancer|February 27, 2008
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous systemPaula Gill, Mark Litzow, Jan Buckner, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2007
Online planning and delivery technique for radiotherapy of spinal metastases using cone-beam CT: image quality and system performanceDaniel Létourneau, Rebecca Wong, Douglas Moseley, et al.
Leukemia & Lymphoma|January 8, 2024
The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphomaChonlada Laoruangroj, Pamela J Atherton, Gregory A Wiseman, et al.
American Journal of Hematology|September 16, 2010
IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemiaSteven R Schuster, Sundararajan Vincent Rajkumar, Angela Dispenzieri, et al.
Blood|August 31, 2016
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapyBruce D Cheson, Stephen Ansell, Larry Schwartz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphomaEmilian Racila, Brian K Link, Wen-Kai Weng, et al.
American Journal of Hematology|April 7, 2017
Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphomaMoritz Binder, Megan M O'Byrne, Matthew J Maurer, et al.
Leukemia & Lymphoma|November 23, 2022
Central nervous system involvement by mantle cell lymphomaNicole McLaughlin, Yucai Wang, Thomas Witzig, et al.
Nature Reviews. Clinical Oncology|December 30, 2016
The landscape of new drugs in lymphomaAnas Younes, Stephen Ansell, Nathan Fowler, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Haematologica|July 10, 2012
Molecular pathogenesis of Waldenstrom's macroglobulinemiaEsteban Braggio, Casey Philipsborn, Anne Novak, et al.
Cancer|February 27, 2008
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous systemPaula Gill, Mark Litzow, Jan Buckner, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2007
Online planning and delivery technique for radiotherapy of spinal metastases using cone-beam CT: image quality and system performanceDaniel Létourneau, Rebecca Wong, Douglas Moseley, et al.
Leukemia & Lymphoma|January 8, 2024
The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphomaChonlada Laoruangroj, Pamela J Atherton, Gregory A Wiseman, et al.
American Journal of Hematology|September 16, 2010
IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemiaSteven R Schuster, Sundararajan Vincent Rajkumar, Angela Dispenzieri, et al.
Blood|August 31, 2016
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapyBruce D Cheson, Stephen Ansell, Larry Schwartz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphomaEmilian Racila, Brian K Link, Wen-Kai Weng, et al.
American Journal of Hematology|April 7, 2017
Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphomaMoritz Binder, Megan M O'Byrne, Matthew J Maurer, et al.
Leukemia & Lymphoma|November 23, 2022
Central nervous system involvement by mantle cell lymphomaNicole McLaughlin, Yucai Wang, Thomas Witzig, et al.
Nature Reviews. Clinical Oncology|December 30, 2016
The landscape of new drugs in lymphomaAnas Younes, Stephen Ansell, Nathan Fowler, et al.
Pageof 4